BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20459534)

  • 1. Spindle proteins in resected pancreatic head adenocarcinomas: BubR1 is an independent prognostic factor in pancreatobiliary-type tumours.
    Gladhaug IP; Westgaard A; Schjølberg AR; Burum-Auensen E; Pomianowska E; Clausen OP
    Histopathology; 2010 Feb; 56(3):345-55. PubMed ID: 20459534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry.
    Burum-Auensen E; De Angelis PM; Schjølberg AR; Kravik KL; Aure M; Clausen OP
    J Histochem Cytochem; 2007 May; 55(5):477-86. PubMed ID: 17242465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between reduced expression of the spindle checkpoint protein BubR1 and bad prognosis in tonsillar carcinomas.
    Hannisdal K; Burum-Auensen E; Schjølberg A; De Angelis PM; Clausen OP
    Head Neck; 2010 Oct; 32(10):1354-62. PubMed ID: 20146332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas.
    Link BC; Reichelt U; Schreiber M; Kaifi JT; Wachowiak R; Bogoevski D; Bubenheim M; Cataldegirmen G; Gawad KA; Issa R; Koops S; Izbicki JR; Yekebas EF
    Ann Surg Oncol; 2007 Sep; 14(9):2591-9. PubMed ID: 17549567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
    Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
    Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora kinases as prognostic biomarkers in ovarian carcinoma.
    Mendiola M; Barriuso J; Mariño-Enríquez A; Redondo A; Domínguez-Cáceres A; Hernández-Cortés G; Pérez-Fernández E; Sánchez-Navarro I; Vara JA; Suárez A; Espinosa E; González-Barón M; Palacios J; Hardisson D
    Hum Pathol; 2009 May; 40(5):631-8. PubMed ID: 19157502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
    Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
    Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p27Kip1 expression independently predicts poor prognosis for patients with resectable pancreatic adenocarcinoma.
    Lu CD; Morita S; Ishibashi T; Hara H; Isozaki H; Tanigawa N
    Cancer; 1999 Mar; 85(6):1250-60. PubMed ID: 10189129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
    Infante JR; Matsubayashi H; Sato N; Tonascia J; Klein AP; Riall TA; Yeo C; Iacobuzio-Donahue C; Goggins M
    J Clin Oncol; 2007 Jan; 25(3):319-25. PubMed ID: 17235047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
    Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
    Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
    Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
    J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.
    Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
    BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
    Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
    J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression.
    Johnson VL; Scott MI; Holt SV; Hussein D; Taylor SS
    J Cell Sci; 2004 Mar; 117(Pt 8):1577-89. PubMed ID: 15020684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAD2 as a key component of mitotic checkpoint: A probable prognostic factor for gastric cancer.
    Wang L; Yin F; Du Y; Du W; Chen B; Zhang Y; Wu K; Ding J; Liu J; Fan D
    Am J Clin Pathol; 2009 Jun; 131(6):793-801. PubMed ID: 19461085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
    Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma.
    Kim HS; Kim GY; Lim SJ; Kim YW
    Pathology; 2010 Dec; 42(7):655-60. PubMed ID: 21080875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.